FSHB and cartilage-hair hypoplasia: Whilst luteinizing hormone beta (LHB) and follicle-stimulating hormone beta (FSHB) are not frequently identified with pathogenic variants in CHH cohorts, they have clear biological basis and a strong evidence base for inclusion [45–48].